News|Articles|June 24, 2024
High Throughput Phage Display for Accelerated Antibody Drug Discovery
Author(s)Bio-Rad
Bio-Rad Laboratories, Inc., Pioneer™ Antibody Discovery Platform helps streamline the phage display-based discovery process and provides researchers with superior identification of high-quality therapeutic antibodies.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Green Chemistry’s Role in Advancing US Chemical Innovation
2
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
3
Next-Generation Modalities Drive New Antibody Discovery
4
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
5